NanoPhoria Raises €83.5 Million Series A to Advance Heart Failure Therapy and Expand Nano‑Delivery Platform
NanoPhoria, the Milan‑based biotechnology company pioneering nano‑delivery therapies for cardiovascular disease, has raised €83.5 million in a landmark Series A financing round — one of the largest…
